174 related articles for article (PubMed ID: 35269531)
1. Altered Plasma Fatty Acid Abundance Is Associated with Cachexia in Treatment-Naïve Pancreatic Cancer.
Gumpper-Fedus K; Hart PA; Belury MA; Crowe O; Cole RM; Pita Grisanti V; Badi N; Liva S; Hinton A; Coss C; Ramsey ML; Noonan A; Conwell DL; Cruz-Monserrate Z
Cells; 2022 Mar; 11(5):. PubMed ID: 35269531
[TBL] [Abstract][Full Text] [Related]
2. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.
Winnard PT; Bharti SK; Sharma RK; Krishnamachary B; Mironchik Y; Penet MF; Goggins MG; Maitra A; Kamel I; Horton KM; Jacobs MA; Bhujwalla ZM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1487-1500. PubMed ID: 33006443
[TBL] [Abstract][Full Text] [Related]
3. Alterations in plasma and tumour levels of fatty acids with weight loss in an experimental cachexia model.
Hudson EA; Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 1994 May; 50(5):229-34. PubMed ID: 8066096
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
[TBL] [Abstract][Full Text] [Related]
5. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.
Ramsey ML; Talbert E; Ahn D; Bekaii-Saab T; Badi N; Bloomston PM; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Farren MR; Hinton A; Krishna SG; Lesinski GB; Mace T; Manilchuk A; Noonan A; Pawlik TM; Rajasekera PV; Schmidt C; Guttridge D; Hart PA
Pancreatology; 2019 Jan; 19(1):80-87. PubMed ID: 30497874
[TBL] [Abstract][Full Text] [Related]
6. The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes.
Dunne RF; Roeland EJ
Hematol Oncol Clin North Am; 2022 Oct; 36(5):897-910. PubMed ID: 36154783
[TBL] [Abstract][Full Text] [Related]
7. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
[TBL] [Abstract][Full Text] [Related]
8. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
9. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
[TBL] [Abstract][Full Text] [Related]
10. Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives.
Cortez NE; Mackenzie GG
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579079
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Fatty Acid Profiles in a Group of Female Patients with Chronic Kidney Diseases (CKD) and Metabolic Syndrome (MetS)⁻Similar Trends of Changes, Different Pathophysiology.
Szczuko M; Kaczkan M; Drozd A; Maciejewska D; Palma J; Owczarzak A; Marczuk N; Rutkowski P; Małgorzewicz S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959940
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
[TBL] [Abstract][Full Text] [Related]
13. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
14. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
15. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators?
Rossmeislová L; Gojda J; Smolková K
Cancer Metastasis Rev; 2021 Dec; 40(4):1115-1139. PubMed ID: 34962613
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
18. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.
Saunders EF; Reider A; Singh G; Gelenberg AJ; Rapoport SI
Bipolar Disord; 2015 Nov; 17(7):729-42. PubMed ID: 26424416
[TBL] [Abstract][Full Text] [Related]
19. Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status.
Chovsepian A; Prokopchuk O; Petrova G; Gjini T; Kuzi H; Heisz S; Janssen KP; Martignoni ME; Friess H; Hauner H; Rohm M
Mol Metab; 2023 Jul; 73():101729. PubMed ID: 37094629
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
